-
1
-
-
84887627398
-
Antibiotic resistance-the need for global solutions
-
Laxminarayan R., Duse A., Wattal C., et al. Antibiotic resistance-the need for global solutions. Lancet Infect Dis 2013, 13(12):1057-1098.
-
(2013)
Lancet Infect Dis
, vol.13
, Issue.12
, pp. 1057-1098
-
-
Laxminarayan, R.1
Duse, A.2
Wattal, C.3
-
2
-
-
84944700095
-
-
Accessed April 1
-
Available at:. Accessed April 1, 2015. http://www.cdc.gov/drugresistance/index.html.
-
(2015)
-
-
-
3
-
-
27144490073
-
Extended-spectrum beta-lactamases: a clinical update
-
Paterson D.L., Bonomo R.A. Extended-spectrum beta-lactamases: a clinical update. Clin Microbiol Rev 2005, 18(4):657-686.
-
(2005)
Clin Microbiol Rev
, vol.18
, Issue.4
, pp. 657-686
-
-
Paterson, D.L.1
Bonomo, R.A.2
-
4
-
-
39049128343
-
Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern
-
Pitout J.D., Laupland K.B. Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis 2008, 8(3):159-166.
-
(2008)
Lancet Infect Dis
, vol.8
, Issue.3
, pp. 159-166
-
-
Pitout, J.D.1
Laupland, K.B.2
-
5
-
-
0021024916
-
Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens
-
Knothe H., Shah P., Krcmery V., et al. Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens. Infection 1983, 11(6):315-317.
-
(1983)
Infection
, vol.11
, Issue.6
, pp. 315-317
-
-
Knothe, H.1
Shah, P.2
Krcmery, V.3
-
6
-
-
0023690533
-
Broad-spectrum, transmissible beta-lactamases
-
Jacoby G.A., Medeiros A.A., O'Brien T.F., et al. Broad-spectrum, transmissible beta-lactamases. N Engl J Med 1988, 319(11):723-724.
-
(1988)
N Engl J Med
, vol.319
, Issue.11
, pp. 723-724
-
-
Jacoby, G.A.1
Medeiros, A.A.2
O'Brien, T.F.3
-
8
-
-
84884650083
-
Comparative analysis of ESBL-positive Escherichia coli isolates from animals and humans from the UK, the Netherlands and Germany
-
Wu G., Day M.J., Mafura M.T., et al. Comparative analysis of ESBL-positive Escherichia coli isolates from animals and humans from the UK, the Netherlands and Germany. PLoS One 2013, 8(9):e75392.
-
(2013)
PLoS One
, vol.8
, Issue.9
, pp. e75392
-
-
Wu, G.1
Day, M.J.2
Mafura, M.T.3
-
9
-
-
73949121686
-
Food reservoir for Escherichia coli causing urinary tract infections
-
Vincent C., Boerlin P., Daignault D., et al. Food reservoir for Escherichia coli causing urinary tract infections. Emerg Infect Dis 2010, 16(1):88-95.
-
(2010)
Emerg Infect Dis
, vol.16
, Issue.1
, pp. 88-95
-
-
Vincent, C.1
Boerlin, P.2
Daignault, D.3
-
10
-
-
84861210836
-
ESBL-positive Enterobacteria isolates in drinking water
-
De Boeck H., Miwanda B., Lunguya-Metila O., et al. ESBL-positive Enterobacteria isolates in drinking water. Emerg Infect Dis 2012, 18(6):1019-1020.
-
(2012)
Emerg Infect Dis
, vol.18
, Issue.6
, pp. 1019-1020
-
-
De Boeck, H.1
Miwanda, B.2
Lunguya-Metila, O.3
-
11
-
-
79951529601
-
Isolation of fluoroquinolone-resistant O25b:H4-ST131 Escherichia coli with CTX-M-14 extended-spectrum beta-lactamase from UK river water
-
Dhanji H., Murphy N.M., Akhigbe C., et al. Isolation of fluoroquinolone-resistant O25b:H4-ST131 Escherichia coli with CTX-M-14 extended-spectrum beta-lactamase from UK river water. J Antimicrob Chemother 2011, 66(3):512-516.
-
(2011)
J Antimicrob Chemother
, vol.66
, Issue.3
, pp. 512-516
-
-
Dhanji, H.1
Murphy, N.M.2
Akhigbe, C.3
-
12
-
-
70449631445
-
Sharing of Escherichia coli sequence type ST131 and other multidrug-resistant and Urovirulent E. coli strains among dogs and cats within a household
-
Johnson J.R., Miller S., Johnston B., et al. Sharing of Escherichia coli sequence type ST131 and other multidrug-resistant and Urovirulent E. coli strains among dogs and cats within a household. J Clin Microbiol 2009, 47(11):3721-3725.
-
(2009)
J Clin Microbiol
, vol.47
, Issue.11
, pp. 3721-3725
-
-
Johnson, J.R.1
Miller, S.2
Johnston, B.3
-
13
-
-
0035873724
-
Variations in the prevalence of strains expressing an extended-spectrum beta-lactamase phenotype and characterization of isolates from Europe, the Americas, and the Western Pacific region
-
Winokur P.L., Canton R., Casellas J.M., et al. Variations in the prevalence of strains expressing an extended-spectrum beta-lactamase phenotype and characterization of isolates from Europe, the Americas, and the Western Pacific region. Clin Infect Dis 2001, 32(Suppl 2):S94-S103.
-
(2001)
Clin Infect Dis
, vol.32
, pp. S94-S103
-
-
Winokur, P.L.1
Canton, R.2
Casellas, J.M.3
-
14
-
-
70149090868
-
A multinational survey of risk factors for infection with extended-spectrum beta-lactamase-producing enterobacteriaceae in nonhospitalized patients
-
Ben-Ami R., Rodríguez-Baño J., Arslan H., et al. A multinational survey of risk factors for infection with extended-spectrum beta-lactamase-producing enterobacteriaceae in nonhospitalized patients. Clin Infect Dis 2009, 49(5):682-690.
-
(2009)
Clin Infect Dis
, vol.49
, Issue.5
, pp. 682-690
-
-
Ben-Ami, R.1
Rodríguez-Baño, J.2
Arslan, H.3
-
15
-
-
84862573595
-
Impact of cefepime therapy on mortality among patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli
-
Chopra T., Marchaim D., Veltman J., et al. Impact of cefepime therapy on mortality among patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli. Antimicrob Agents Chemother 2012, 56(7):3936-3942.
-
(2012)
Antimicrob Agents Chemother
, vol.56
, Issue.7
, pp. 3936-3942
-
-
Chopra, T.1
Marchaim, D.2
Veltman, J.3
-
16
-
-
10744230588
-
Cefepime versus imipenem-cilastatin for treatment of nosocomial pneumonia in intensive care unit patients: a multicenter, evaluator-blind, prospective, randomized study
-
Zanetti G., Bally F., Greub G., et al. Cefepime versus imipenem-cilastatin for treatment of nosocomial pneumonia in intensive care unit patients: a multicenter, evaluator-blind, prospective, randomized study. Antimicrob Agents Chemother 2003, 47(11):3442-3447.
-
(2003)
Antimicrob Agents Chemother
, vol.47
, Issue.11
, pp. 3442-3447
-
-
Zanetti, G.1
Bally, F.2
Greub, G.3
-
17
-
-
33744483523
-
Clinical correlation of the CLSI susceptibility breakpoint for piperacillin- tazobactam against extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella species
-
Gavin P.J., Suseno M.T., Thomson R.B., et al. Clinical correlation of the CLSI susceptibility breakpoint for piperacillin- tazobactam against extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella species. Antimicrob Agents Chemother 2006, 50(6):2244-2247.
-
(2006)
Antimicrob Agents Chemother
, vol.50
, Issue.6
, pp. 2244-2247
-
-
Gavin, P.J.1
Suseno, M.T.2
Thomson, R.B.3
-
18
-
-
0037282428
-
Extended spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae: considerations for diagnosis, prevention and drug treatment
-
Rupp M.E., Fey P.D. Extended spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae: considerations for diagnosis, prevention and drug treatment. Drugs 2003, 63(4):353-365.
-
(2003)
Drugs
, vol.63
, Issue.4
, pp. 353-365
-
-
Rupp, M.E.1
Fey, P.D.2
-
19
-
-
84869489961
-
Nitrofurantoin in the treatment of extended-spectrum beta-lactamase-producing Escherichia coli-related lower urinary tract infection
-
Tasbakan M.I., Pullukcu H., Sipahi O.R., et al. Nitrofurantoin in the treatment of extended-spectrum beta-lactamase-producing Escherichia coli-related lower urinary tract infection. Int J Antimicrob Agents 2012, 40(6):554-556.
-
(2012)
Int J Antimicrob Agents
, vol.40
, Issue.6
, pp. 554-556
-
-
Tasbakan, M.I.1
Pullukcu, H.2
Sipahi, O.R.3
-
20
-
-
72149117149
-
Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum beta-lactamase producing, Enterobacteriaceae infections: a systematic review
-
Falagas M.E., Kastoris A.C., Kapaskelis A.M., et al. Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum beta-lactamase producing, Enterobacteriaceae infections: a systematic review. Lancet Infect Dis 2010, 10(1):43-50.
-
(2010)
Lancet Infect Dis
, vol.10
, Issue.1
, pp. 43-50
-
-
Falagas, M.E.1
Kastoris, A.C.2
Kapaskelis, A.M.3
-
21
-
-
84861109391
-
Effects of confounders and intermediates on the association of bacteraemia caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae and patient outcome: a meta-analysis
-
Rottier W.C., Ammerlaan H.S., Bonten M.J., et al. Effects of confounders and intermediates on the association of bacteraemia caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae and patient outcome: a meta-analysis. J Antimicrob Chemother 2012, 67(6):1311-1320.
-
(2012)
J Antimicrob Chemother
, vol.67
, Issue.6
, pp. 1311-1320
-
-
Rottier, W.C.1
Ammerlaan, H.S.2
Bonten, M.J.3
-
22
-
-
35348821803
-
A step closer to extreme drug resistance (XDR) in gram-negative bacilli
-
Paterson D.L., Doi Y. A step closer to extreme drug resistance (XDR) in gram-negative bacilli. Clin Infect Dis 2007, 45(9):1179-1181.
-
(2007)
Clin Infect Dis
, vol.45
, Issue.9
, pp. 1179-1181
-
-
Paterson, D.L.1
Doi, Y.2
-
23
-
-
24044518439
-
Carbapenemase-producing Klebsiella pneumoniae in Brooklyn, NY: molecular epidemiology and in vitro activity of polymyxin B and other agents
-
Bratu S., Tolaney P., Karumudi U., et al. Carbapenemase-producing Klebsiella pneumoniae in Brooklyn, NY: molecular epidemiology and in vitro activity of polymyxin B and other agents. J Antimicrob Chemother 2005, 56(1):128-132.
-
(2005)
J Antimicrob Chemother
, vol.56
, Issue.1
, pp. 128-132
-
-
Bratu, S.1
Tolaney, P.2
Karumudi, U.3
-
24
-
-
34547422759
-
Carbapenemases: the versatile beta-lactamases
-
table of contents
-
Queenan A.M., Bush K. Carbapenemases: the versatile beta-lactamases. Clin Microbiol Rev 2007, 20(3):440-458. table of contents.
-
(2007)
Clin Microbiol Rev
, vol.20
, Issue.3
, pp. 440-458
-
-
Queenan, A.M.1
Bush, K.2
-
25
-
-
79951829390
-
Carbapenem resistance in Klebsiella pneumoniae due to the New Delhi Metallo-beta-lactamase
-
Sidjabat H., Nimmo G.R., Walsh T.R., et al. Carbapenem resistance in Klebsiella pneumoniae due to the New Delhi Metallo-beta-lactamase. Clin Infect Dis 2011, 52(4):481-484.
-
(2011)
Clin Infect Dis
, vol.52
, Issue.4
, pp. 481-484
-
-
Sidjabat, H.1
Nimmo, G.R.2
Walsh, T.R.3
-
26
-
-
84875181975
-
Global spread of antibiotic resistance: the example of New Delhi metallo-beta-lactamase (NDM)-mediated carbapenem resistance
-
Johnson A.P., Woodford N. Global spread of antibiotic resistance: the example of New Delhi metallo-beta-lactamase (NDM)-mediated carbapenem resistance. J Med Microbiol 2013, 62(Pt 4):499-513.
-
(2013)
J Med Microbiol
, vol.62
, pp. 499-513
-
-
Johnson, A.P.1
Woodford, N.2
-
27
-
-
0035084032
-
Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae
-
Yigit H., Queenan A.M., Anderson G.J., et al. Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother 2001, 45(4):1151-1161.
-
(2001)
Antimicrob Agents Chemother
, vol.45
, Issue.4
, pp. 1151-1161
-
-
Yigit, H.1
Queenan, A.M.2
Anderson, G.J.3
-
28
-
-
84876339272
-
"Nightmare" bacteria on the rise in US hospitals, long-term care facilities
-
Kuehn B.M. "Nightmare" bacteria on the rise in US hospitals, long-term care facilities. JAMA 2013, 309(15):1573-1574.
-
(2013)
JAMA
, vol.309
, Issue.15
, pp. 1573-1574
-
-
Kuehn, B.M.1
-
29
-
-
84870946642
-
Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009-2010
-
Sievert D.M., Ricks P., Edwards J.R., et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009-2010. Infect Control Hosp Epidemiol 2013, 34(1):1-14.
-
(2013)
Infect Control Hosp Epidemiol
, vol.34
, Issue.1
, pp. 1-14
-
-
Sievert, D.M.1
Ricks, P.2
Edwards, J.R.3
-
30
-
-
84930486688
-
Global spread of carbapenemase-producing enterobacteriaceae
-
Nordmann P., Naas T., Poirel L., et al. Global spread of carbapenemase-producing enterobacteriaceae. Emerg Infect Dis 2011, 17(10):1791-1798.
-
(2011)
Emerg Infect Dis
, vol.17
, Issue.10
, pp. 1791-1798
-
-
Nordmann, P.1
Naas, T.2
Poirel, L.3
-
31
-
-
40549126250
-
Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality
-
Schwaber M.J., Klarfeld-Lidji S., Navon-Venezia S., et al. Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality. Antimicrob Agents Chemother 2008, 52(3):1028-1033.
-
(2008)
Antimicrob Agents Chemother
, vol.52
, Issue.3
, pp. 1028-1033
-
-
Schwaber, M.J.1
Klarfeld-Lidji, S.2
Navon-Venezia, S.3
-
32
-
-
56749155916
-
Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies
-
Patel G., Huprikar S., Factor S.H., et al. Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies. Infect Control Hosp Epidemiol 2008, 29(12):1099-1106.
-
(2008)
Infect Control Hosp Epidemiol
, vol.29
, Issue.12
, pp. 1099-1106
-
-
Patel, G.1
Huprikar, S.2
Factor, S.H.3
-
33
-
-
84874894245
-
Vital signs: carbapenem-resistant Enterobacteriaceae
-
Centers for Disease Control and Prevention (CDC) Vital signs: carbapenem-resistant Enterobacteriaceae. MMWR Morb Mortal Wkly Rep 2013, 62(9):165-170.
-
(2013)
MMWR Morb Mortal Wkly Rep
, vol.62
, Issue.9
, pp. 165-170
-
-
-
34
-
-
80052247996
-
Emergence and rapid regional spread of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae
-
Won S.Y., Munoz-Price L.S., Lolans K., et al. Emergence and rapid regional spread of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae. Clin Infect Dis 2011, 53(6):532-540.
-
(2011)
Clin Infect Dis
, vol.53
, Issue.6
, pp. 532-540
-
-
Won, S.Y.1
Munoz-Price, L.S.2
Lolans, K.3
-
35
-
-
84865323065
-
Tracking a hospital outbreak of carbapenem-resistant Klebsiella pneumoniae with whole-genome sequencing
-
Snitkin E.S., Zelazny A.M., Thomas P.J., et al. Tracking a hospital outbreak of carbapenem-resistant Klebsiella pneumoniae with whole-genome sequencing. Sci Transl Med 2012, 4(148):148ra116.
-
(2012)
Sci Transl Med
, vol.4
, Issue.148
, pp. 148ra116
-
-
Snitkin, E.S.1
Zelazny, A.M.2
Thomas, P.J.3
-
36
-
-
84862146733
-
Treatment and clinical outcomes of urinary tract infections caused by KPC-producing Enterobacteriaceae in a retrospective cohort
-
Alexander B.T., Marschall J., Tibbetts R.J., et al. Treatment and clinical outcomes of urinary tract infections caused by KPC-producing Enterobacteriaceae in a retrospective cohort. Clin Ther 2012, 34(6):1314-1323.
-
(2012)
Clin Ther
, vol.34
, Issue.6
, pp. 1314-1323
-
-
Alexander, B.T.1
Marschall, J.2
Tibbetts, R.J.3
-
37
-
-
84866072596
-
Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy
-
Tumbarello M., Viale P., Viscoli C., et al. Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy. Clin Infect Dis 2012, 55(7):943-950.
-
(2012)
Clin Infect Dis
, vol.55
, Issue.7
, pp. 943-950
-
-
Tumbarello, M.1
Viale, P.2
Viscoli, C.3
-
38
-
-
83655201460
-
Outcome of carbapenem resistant Klebsiella pneumoniae bloodstream infections
-
Ben-David D., Kordevani R., Keller N., et al. Outcome of carbapenem resistant Klebsiella pneumoniae bloodstream infections. Clin Microbiol Infect 2012, 18(1):54-60.
-
(2012)
Clin Microbiol Infect
, vol.18
, Issue.1
, pp. 54-60
-
-
Ben-David, D.1
Kordevani, R.2
Keller, N.3
-
39
-
-
80054088449
-
Incidence of and risk factors for colistin-associated nephrotoxicity in a large academic health system
-
Pogue J.M., Lee J., Marchaim D., et al. Incidence of and risk factors for colistin-associated nephrotoxicity in a large academic health system. Clin Infect Dis 2011, 53(9):879-884.
-
(2011)
Clin Infect Dis
, vol.53
, Issue.9
, pp. 879-884
-
-
Pogue, J.M.1
Lee, J.2
Marchaim, D.3
-
40
-
-
0021348796
-
Risk factors for nephrotoxicity in patients treated with aminoglycosides
-
Moore R.D., Smith C.R., Lipsky J.J., et al. Risk factors for nephrotoxicity in patients treated with aminoglycosides. Ann Intern Med 1984, 100(3):352-357.
-
(1984)
Ann Intern Med
, vol.100
, Issue.3
, pp. 352-357
-
-
Moore, R.D.1
Smith, C.R.2
Lipsky, J.J.3
-
41
-
-
84875971014
-
The global spread of healthcare-associated multidrug-resistant bacteria: a perspective from Asia
-
Molton J.S., Tambyah P.A., Ang B.S., et al. The global spread of healthcare-associated multidrug-resistant bacteria: a perspective from Asia. Clin Infect Dis 2013, 56(9):1310-1318.
-
(2013)
Clin Infect Dis
, vol.56
, Issue.9
, pp. 1310-1318
-
-
Molton, J.S.1
Tambyah, P.A.2
Ang, B.S.3
-
42
-
-
84907690490
-
New Delhi metallo-beta-lactamase-producing carbapenem-resistant Escherichia coli associated with exposure to duodenoscopes
-
Epstein L., Hunter J.C., Arwady M.A., et al. New Delhi metallo-beta-lactamase-producing carbapenem-resistant Escherichia coli associated with exposure to duodenoscopes. JAMA 2014, 312(14):1447-1455.
-
(2014)
JAMA
, vol.312
, Issue.14
, pp. 1447-1455
-
-
Epstein, L.1
Hunter, J.C.2
Arwady, M.A.3
-
43
-
-
56049089389
-
Current control and treatment of multidrug-resistant Acinetobacter baumannii infections
-
Karageorgopoulos D.E., Falagas M.E. Current control and treatment of multidrug-resistant Acinetobacter baumannii infections. Lancet Infect Dis 2008, 8(12):751-762.
-
(2008)
Lancet Infect Dis
, vol.8
, Issue.12
, pp. 751-762
-
-
Karageorgopoulos, D.E.1
Falagas, M.E.2
-
44
-
-
36248932659
-
An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii
-
Dijkshoorn L., Nemec A., Seifert H., et al. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat Rev Microbiol 2007, 5(12):939-951.
-
(2007)
Nat Rev Microbiol
, vol.5
, Issue.12
, pp. 939-951
-
-
Dijkshoorn, L.1
Nemec, A.2
Seifert, H.3
-
45
-
-
33747625237
-
Mechanisms of multidrug resistance in Acinetobacter species and Pseudomonas aeruginosa
-
Bonomo R.A., Szabo D. Mechanisms of multidrug resistance in Acinetobacter species and Pseudomonas aeruginosa. Clin Infect Dis 2006, 43(Suppl 2):S49-S56.
-
(2006)
Clin Infect Dis
, vol.43
, pp. S49-S56
-
-
Bonomo, R.A.1
Szabo, D.2
-
46
-
-
0030856704
-
Distribution of Acinetobacter species on human skin: comparison of phenotypic and genotypic identification methods
-
Seifert H., Dijkshoorn L., Gerner-Smidt P., et al. Distribution of Acinetobacter species on human skin: comparison of phenotypic and genotypic identification methods. J Clin Microbiol 1997, 35(11):2819-2825.
-
(1997)
J Clin Microbiol
, vol.35
, Issue.11
, pp. 2819-2825
-
-
Seifert, H.1
Dijkshoorn, L.2
Gerner-Smidt, P.3
-
47
-
-
0032811295
-
Skin carriage of acinetobacters in Hong Kong
-
Chu Y.W., Leung C.M., Houang E.T., et al. Skin carriage of acinetobacters in Hong Kong. J Clin Microbiol 1999, 37(9):2962-2967.
-
(1999)
J Clin Microbiol
, vol.37
, Issue.9
, pp. 2962-2967
-
-
Chu, Y.W.1
Leung, C.M.2
Houang, E.T.3
-
48
-
-
35948941509
-
Community-acquired Acinetobacter infections
-
Falagas M.E., Karveli E.A., Kelesidis I., et al. Community-acquired Acinetobacter infections. Eur J Clin Microbiol Infect Dis 2007, 26(12):857-868.
-
(2007)
Eur J Clin Microbiol Infect Dis
, vol.26
, Issue.12
, pp. 857-868
-
-
Falagas, M.E.1
Karveli, E.A.2
Kelesidis, I.3
-
49
-
-
33847027647
-
Carbapenem-resistant Acinetobacter baumannii in intensive care unit patients: risk factors for acquisition, infection and their consequences
-
Playford E.G., Craig J.C., Iredell J.R., et al. Carbapenem-resistant Acinetobacter baumannii in intensive care unit patients: risk factors for acquisition, infection and their consequences. J Hosp Infect 2007, 65(3):204-211.
-
(2007)
J Hosp Infect
, vol.65
, Issue.3
, pp. 204-211
-
-
Playford, E.G.1
Craig, J.C.2
Iredell, J.R.3
-
50
-
-
33144460009
-
The epidemiology and control of Acinetobacter baumannii in health care facilities
-
Fournier P.E., Richet H. The epidemiology and control of Acinetobacter baumannii in health care facilities. Clin Infect Dis 2006, 42(5):692-699.
-
(2006)
Clin Infect Dis
, vol.42
, Issue.5
, pp. 692-699
-
-
Fournier, P.E.1
Richet, H.2
-
51
-
-
34249909267
-
An outbreak of multidrug-resistant Acinetobacter baumannii-calcoaceticus complex infection in the US military health care system associated with military operations in Iraq
-
Scott P., Deye G., Srinivasan A., et al. An outbreak of multidrug-resistant Acinetobacter baumannii-calcoaceticus complex infection in the US military health care system associated with military operations in Iraq. Clin Infect Dis 2007, 44(12):1577-1584.
-
(2007)
Clin Infect Dis
, vol.44
, Issue.12
, pp. 1577-1584
-
-
Scott, P.1
Deye, G.2
Srinivasan, A.3
-
52
-
-
35448962165
-
Antimicrobial susceptibility among organisms from the Asia/Pacific Rim, Europe and Latin and North America collected as part of TEST and the in vitro activity of tigecycline
-
Reinert R.R., Low D.E., Rossi F., et al. Antimicrobial susceptibility among organisms from the Asia/Pacific Rim, Europe and Latin and North America collected as part of TEST and the in vitro activity of tigecycline. J Antimicrob Chemother 2007, 60(5):1018-1029.
-
(2007)
J Antimicrob Chemother
, vol.60
, Issue.5
, pp. 1018-1029
-
-
Reinert, R.R.1
Low, D.E.2
Rossi, F.3
-
53
-
-
84955747361
-
Treatment of carbapenem-resistant acinetobacter baumannii ventilator-associated pneumonia: retrospective comparison between intravenous colistin and intravenous ampicillin-sulbactam
-
[Epub ahead of print]
-
Zalts R., Neuberger A., Hussein K., et al. Treatment of carbapenem-resistant acinetobacter baumannii ventilator-associated pneumonia: retrospective comparison between intravenous colistin and intravenous ampicillin-sulbactam. Am J Ther 2013, [Epub ahead of print].
-
(2013)
Am J Ther
-
-
Zalts, R.1
Neuberger, A.2
Hussein, K.3
-
54
-
-
77957882351
-
Clinical outcomes of carbapenem-resistant Acinetobacter baumannii bloodstream infections: study of a 2-state monoclonal outbreak
-
Munoz-Price L.S., Zembower T., Penugonda S., et al. Clinical outcomes of carbapenem-resistant Acinetobacter baumannii bloodstream infections: study of a 2-state monoclonal outbreak. Infect Control Hosp Epidemiol 2010, 31(10):1057-1062.
-
(2010)
Infect Control Hosp Epidemiol
, vol.31
, Issue.10
, pp. 1057-1062
-
-
Munoz-Price, L.S.1
Zembower, T.2
Penugonda, S.3
-
55
-
-
3943093972
-
Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study
-
Wisplinghoff H., Bischoff T., Tallent S.M., et al. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004, 39(3):309-317.
-
(2004)
Clin Infect Dis
, vol.39
, Issue.3
, pp. 309-317
-
-
Wisplinghoff, H.1
Bischoff, T.2
Tallent, S.M.3
-
56
-
-
33746093374
-
Attributable mortality of Acinetobacter baumannii infections in critically ill patients: a systematic review of matched cohort and case-control studies
-
Falagas M.E., Bliziotis I.A., Siempos, et al. Attributable mortality of Acinetobacter baumannii infections in critically ill patients: a systematic review of matched cohort and case-control studies. Crit Care 2006, 10(2):R48.
-
(2006)
Crit Care
, vol.10
, Issue.2
, pp. R48
-
-
Falagas, M.E.1
Bliziotis, I.A.2
Siempos3
-
57
-
-
0037352118
-
Nosocomial bacteremia involving Acinetobacter baumannii in critically ill patients: a matched cohort study
-
Blot S., Vandewoude K., Colardyn F., et al. Nosocomial bacteremia involving Acinetobacter baumannii in critically ill patients: a matched cohort study. Intensive Care Med 2003, 29(3):471-475.
-
(2003)
Intensive Care Med
, vol.29
, Issue.3
, pp. 471-475
-
-
Blot, S.1
Vandewoude, K.2
Colardyn, F.3
-
58
-
-
70449124604
-
Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms
-
Lister P.D., Wolter D.J., Hanson N.D., et al. Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms. Clin Microbiol Rev 2009, 22(4):582-610.
-
(2009)
Clin Microbiol Rev
, vol.22
, Issue.4
, pp. 582-610
-
-
Lister, P.D.1
Wolter, D.J.2
Hanson, N.D.3
-
59
-
-
84857646835
-
Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
-
Magiorakos A.P., Srinivasan A., Carey R.B., et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012, 18(3):268-281.
-
(2012)
Clin Microbiol Infect
, vol.18
, Issue.3
, pp. 268-281
-
-
Magiorakos, A.P.1
Srinivasan, A.2
Carey, R.B.3
-
60
-
-
0021491688
-
Epidemiology of infections due to Pseudomonas aeruginosa
-
Morrison A.J., Wenzel R.P. Epidemiology of infections due to Pseudomonas aeruginosa. Rev Infect Dis 1984, 6(Suppl 3):S627-S642.
-
(1984)
Rev Infect Dis
, vol.6
, pp. S627-S642
-
-
Morrison, A.J.1
Wenzel, R.P.2
-
61
-
-
84873092022
-
Meropenem as predictive risk factor for isolation of multidrug-resistant Pseudomonas aeruginosa
-
Nakamura A., Miyake K., Misawa S., et al. Meropenem as predictive risk factor for isolation of multidrug-resistant Pseudomonas aeruginosa. J Hosp Infect 2013, 83(2):153-155.
-
(2013)
J Hosp Infect
, vol.83
, Issue.2
, pp. 153-155
-
-
Nakamura, A.1
Miyake, K.2
Misawa, S.3
-
62
-
-
29944446141
-
Multidrug-resistant Pseudomonas aeruginosa: risk factors and clinical impact
-
Aloush V., Navon-Venezia S., Seigman-Igra Y., et al. Multidrug-resistant Pseudomonas aeruginosa: risk factors and clinical impact. Antimicrob Agents Chemother 2006, 50(1):43-48.
-
(2006)
Antimicrob Agents Chemother
, vol.50
, Issue.1
, pp. 43-48
-
-
Aloush, V.1
Navon-Venezia, S.2
Seigman-Igra, Y.3
-
63
-
-
0036677948
-
An outbreak of multidrug-resistant Pseudomonas aeruginosa associated with increased risk of patient death in an intensive care unit
-
Bukholm G., Tannaes T., Kjelsberg A.B., et al. An outbreak of multidrug-resistant Pseudomonas aeruginosa associated with increased risk of patient death in an intensive care unit. Infect Control Hosp Epidemiol 2002, 23(8):441-446.
-
(2002)
Infect Control Hosp Epidemiol
, vol.23
, Issue.8
, pp. 441-446
-
-
Bukholm, G.1
Tannaes, T.2
Kjelsberg, A.B.3
-
64
-
-
71549131283
-
Pseudomonas aeruginosa: a formidable and ever-present adversary
-
Kerr K.G., Snelling A.M. Pseudomonas aeruginosa: a formidable and ever-present adversary. J Hosp Infect 2009, 73(4):338-344.
-
(2009)
J Hosp Infect
, vol.73
, Issue.4
, pp. 338-344
-
-
Kerr, K.G.1
Snelling, A.M.2
-
65
-
-
77956104810
-
Impact of multidrug-resistant Pseudomonas aeruginosa bacteremia on patient outcomes
-
Tam V.H., Rogers C.A., Chang K.T., et al. Impact of multidrug-resistant Pseudomonas aeruginosa bacteremia on patient outcomes. Antimicrob Agents Chemother 2010, 54(9):3717-3722.
-
(2010)
Antimicrob Agents Chemother
, vol.54
, Issue.9
, pp. 3717-3722
-
-
Tam, V.H.1
Rogers, C.A.2
Chang, K.T.3
-
66
-
-
84944700096
-
-
Accessed April 1
-
Available at:. Accessed April 1, 2015. http://www.cdc.gov/drugresistance/pdf/ar-threats-2013-508.pdf.
-
(2015)
-
-
-
67
-
-
79953874331
-
Infection reduction strategies including antibiotic stewardship protocols in surgical and trauma intensive care units are associated with reduced resistant gram-negative healthcare-associated infections
-
Dortch M.J., Fleming S.B., Kauffmann R.M., et al. Infection reduction strategies including antibiotic stewardship protocols in surgical and trauma intensive care units are associated with reduced resistant gram-negative healthcare-associated infections. Surg Infect (Larchmt) 2011, 12(1):15-25.
-
(2011)
Surg Infect (Larchmt)
, vol.12
, Issue.1
, pp. 15-25
-
-
Dortch, M.J.1
Fleming, S.B.2
Kauffmann, R.M.3
|